Flotek Industries (FTK) Earnings Date & Reports

Key Takeaways

• Flotek reported third quarter 2026 total revenue of $114.4 million, up 104% year over year and its highest quarterly revenue level in twelve years.
• Diluted earnings per share (EPS, or profit allocated to each outstanding share) came in at $0.34, well above the consensus estimate of about $0.21.
• Revenue of $114.35 million exceeded the analyst consensus of roughly $92.79 million, driven by strong growth in both the Data Analytics and Chemistry Technologies segments.
• The company raised its full-year 2026 guidance to $382–$390 million in revenue and $59–$62 million in Adjusted EBITDA.
• Adjusted EBITDA (a profitability measure that strips out interest, taxes, depreciation, and amortization) reached $19.5 million, an 87% increase from the prior-year quarter.
• For more details on FTK's Major News, Today's Price Move, Price Targets, and Forecast, be sure to explore the additional pages.
• Discover Trending AI Robots to see AI-driven trading strategies in action.

Earnings Context and Why It Matters

Flotek Industries, a Houston-based technology company combining real-time data analytics with advanced chemistry for energy and industrial customers, has been undergoing a deliberate shift toward higher-margin, recurring data services. This third quarter 2026 report is a key checkpoint for that transformation, as investors assess whether the Data Analytics segment can continue its rapid expansion while the Chemistry segment holds up against uneven North American oilfield activity. The results also matter because Flotek's long-term supply relationship with ProFrac Services, a related party, remains a major revenue driver, and international chemistry growth in the Middle East has become an increasingly important swing factor for the top line.

Reported Results

Flotek reported total revenues of $114.4 million for the quarter ended September 30, 2026, a 104% increase from $56.0 million in the same period a year earlier. Both the Chemistry Technologies and Data Analytics segments grew 104% year over year. International Chemistry revenue totaled $28.4 million, up sharply from $2.2 million in the prior-year quarter, reflecting ongoing work in the Middle East.

Gross profit rose 54% to $27.4 million, though gross margin declined to 24% of revenue from 32% a year ago, primarily because of a $7.8 million reduction in revenue tied to minimum purchase requirements under the company's supply agreement with ProFrac Services. Selling, general, and administrative (SG&A) expense was $8.5 million, or 7% of revenue.

Net income was $13.3 million, or $0.34 per diluted share, compared with $20.4 million, or $0.53 per diluted share, a year earlier. The year-ago figure benefited from a $12.6 million non-cash tax benefit, which makes the year-over-year decline less meaningful on an operating basis. Adjusted EBITDA reached $19.5 million, up 87% from $10.4 million. Results comfortably beat analyst expectations, with EPS of $0.34 surpassing the roughly $0.21 consensus and revenue exceeding the approximately $92.79 million estimate.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable criteria such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and broader market opportunities more efficiently than manual screening, making it a practical resource for anyone researching earnings-driven movers like FTK. Explore the AI Screener to streamline your own market research.

Market Reaction and Investor Sentiment

Heading into the report, investor sentiment was constructive, supported by Flotek's track record of consecutive quarterly growth in revenue, net income, and Adjusted EBITDA during 2026. The strong beat on both the top and bottom lines, combined with a second guidance increase this year, reinforced confidence in the company's data-driven strategy. Flotek shares closed at $24.84 ahead of the release, and the results gave investors fresh evidence that the Data Analytics segment—now a leading contributor to gross profit despite a smaller share of revenue—is becoming the primary engine of profitability. Key sentiment drivers include the expanding power services opportunity, growing international chemistry sales, and the recent term loan aimed at funding the Data Analytics capital plan.

Forward Outlook and Key Factors to Monitor

Following the third quarter report, Flotek raised its 2026 guidance to $382–$390 million in total revenue and $59–$62 million in Adjusted EBITDA, up from a prior range of $360–$370 million and $50–$54 million. Investors will be watching whether the fourth quarter can sustain the momentum needed to hit the upper end of that range.

A central area to monitor is the Data Analytics capital investment plan. The company expects 2027 capital expenditures of $15 million to $20 million, funded in part by the term loan closed in September, to expand its inventory of proprietary measurement instruments, grow its fleet of gas conditioning and distribution equipment, and enhance manufacturing capacity. Management has signaled ambitions to extend its real-time measurement technologies beyond oil and gas, including behind-the-meter power generation and other industrial and infrastructure applications.

Other factors to watch include the pace of international chemistry growth in the Middle East, the contribution from the ProFrac related-party supply agreement, and margin trends as Data Analytics becomes a larger share of revenue. Demand for utility infrastructure and distributed power projects will also be an important catalyst for future quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations